Epigenetic silencing of IGFBPL1 promotes esophageal cancer growth by activating PI3K-AKT signaling
暂无分享,去创建一个
Tao He | Lirong Zhang | Lidong Wang | M. Guo | Meiying Zhang | Weili Yang | Yingge Liu
[1] G. Hoxhaj,et al. The PI3K–AKT network at the interface of oncogenic signalling and cancer metabolism , 2019, Nature Reviews Cancer.
[2] Andrew P Feinberg,et al. The Key Role of Epigenetics in Human Disease Prevention and Mitigation. , 2018, The New England journal of medicine.
[3] D. Chen,et al. IGFBPL1 Regulates Axon Growth through IGF-1-mediated Signaling Cascades , 2018, Scientific Reports.
[4] Sheng-Jie Yu,et al. Esophageal cancer: Risk factors, genetic association, and treatment. , 2016, Asian journal of surgery.
[5] J. Herman,et al. Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[6] M. Guo,et al. The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma , 2016, Clinical Epigenetics.
[7] N. Hu,et al. Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer. , 2016, Cancer research.
[8] M. Kashyap. Role of insulin-like growth factor-binding proteins in the pathophysiology and tumorigenesis of gastroesophageal cancers , 2015, Tumor Biology.
[9] Nobhojit Roy,et al. The Global Burden of Cancer 2013. , 2015, JAMA oncology.
[10] H. Atreya,et al. Insulin-Like Growth Factor System in Cancer: Novel Targeted Therapies , 2015, BioMed research international.
[11] J. Herman,et al. Epigenetic changes and functional study of HOXA11 in human gastric cancer. , 2015, Epigenomics.
[12] Jing Wang,et al. Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance , 2014, Genes & diseases.
[13] J. Blenis,et al. The mTORC1/S6K1 Pathway Regulates Glutamine Metabolism through the eIF4B-Dependent Control of c-Myc Translation , 2014, Current Biology.
[14] R. Baxter,et al. IGF binding proteins in cancer: mechanistic and clinical insights , 2014, Nature Reviews Cancer.
[15] Qiang Feng,et al. Identification of genomic alterations in oesophageal squamous cell cancer , 2014, Nature.
[16] J. Herman,et al. Epigenetic regulation of DACH1, a novel Wnt signaling component in colorectal cancer , 2013, Epigenetics.
[17] J. Herman,et al. Epigenetic silencing of CXCL14 induced colorectal cancer migration and invasion. , 2013, Discovery medicine.
[18] J. Herman,et al. Inhibition of SOX17 by microRNA 141 and methylation activates the WNT signaling pathway in esophageal cancer. , 2012, The Journal of molecular diagnostics : JMD.
[19] Yuchen Jiao,et al. Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. , 2012, Cancer discovery.
[20] G. Jin,et al. Epidemiologic differences in esophageal cancer between Asian and Western populations , 2012, Chinese journal of cancer.
[21] Howard Slomko,et al. Minireview: Epigenetics of obesity and diabetes in humans. , 2012, Endocrinology.
[22] Andrew E. Teschendorff,et al. Genome-wide DNA methylation analysis of archival formalin-fixed paraffin-embedded tissue using the Illumina Infinium HumanMethylation27 BeadChip. , 2010, Methods.
[23] S. Blumenthal. From Insulin and Insulin-Like Activity to the Insulin Superfamily of Growth-Promoting Peptides: A 20th-Century Odyssey , 2010, Perspectives in biology and medicine.
[24] E. Montgomery,et al. Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers , 2009, Cancer biology & therapy.
[25] L. Nicholson,et al. Epigenetic Inactivation Implies Independent Functions for Insulin-like Growth Factor Binding Protein (IGFBP)-Related Protein 1 and the Related IGFBPL1 in Inhibiting Breast Cancer Phenotypes , 2007, Clinical Cancer Research.
[26] D. Carbone,et al. Insulin-like growth factor-I receptor as a marker for prognosis and a therapeutic target in human esophageal squamous cell carcinoma. , 2006, Carcinogenesis.
[27] Xiaomei Ma,et al. Global Burden of Cancer , 2006, The Yale journal of biology and medicine.
[28] C. Wild,et al. IGFBP-3 and IGFBP-10 (CYR61) up-regulation during the development of Barrett's oesophagus and associated oesophageal adenocarcinoma: potential biomarkers of disease risk , 2006, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[29] W. Funk,et al. Identification of a novel insulin-like growth factor binding protein gene homologue with tumor suppressor like properties. , 2005, Biochemical and biophysical research communications.
[30] W. El-Deiry,et al. Epidermal Growth Factor Receptor Regulates Aberrant Expression of Insulin-Like Growth Factor-Binding Protein 3 , 2004, Cancer Research.
[31] Tsung-Teh Wu,et al. Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[32] A. Feinberg,et al. Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk , 2003, Science.
[33] Shan-Chun Chen,et al. Autocrine Stimulation by Insulin-Like Growth Factor I Is Involved in the Growth, Tumorigenicity and Chemoresistance of Human Esophageal Carcinoma Cells , 2002, Journal of Biomedical Science.
[34] S. Law,et al. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[35] M. West,et al. Translational induction of the c-myc oncogene via activation of the FRAP/TOR signalling pathway , 1998, Oncogene.
[36] J. Herman,et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[37] R. Rosenfeld,et al. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. , 1993, The Journal of biological chemistry.
[38] Shan-Chun Chen,et al. Overexpression of epidermal growth factor and insulin-like growth factor-I receptors and autocrine stimulation in human esophageal carcinoma cells. , 1991, Cancer research.
[39] J. Schwander,et al. Insulin-Like Growth Factor-Binding Protein , 1989, Definitions.
[40] J. Herman,et al. DACT2 is frequently methylated in human gastric cancer and methylation of DACT2 activated Wnt signaling. , 2014, American journal of cancer research.
[41] J. Luketich,et al. Oesophageal carcinoma , 2013, The Lancet.
[42] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[43] Shan-Chun Chen,et al. Autocrine stimulation by insulin-like growth factor I is involved in the growth, tumorigenicity and chemoresistance of human esophageal carcinoma cells. , 2002, Journal of biomedical science.